Logo image of TRU.CA

TRU PRECIOUS METALS CORP (TRU.CA) Stock Fundamental Analysis

TSX-V:TRU - TSX Venture Exchange - CA89778V1040 - Common Stock - Currency: CAD

0.025  +0.01 (+25%)

Fundamental Rating

2

Taking everything into account, TRU scores 2 out of 10 in our fundamental rating. TRU was compared to 818 industry peers in the Metals & Mining industry. While TRU has a great health rating, there are worries on its profitability. TRU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TRU had negative earnings in the past year.
In the past year TRU has reported a negative cash flow from operations.
TRU.CA Yearly Net Income VS EBIT VS OCF VS FCFTRU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

The Return On Assets of TRU (-65.02%) is worse than 68.34% of its industry peers.
TRU's Return On Equity of -72.55% is on the low side compared to the rest of the industry. TRU is outperformed by 61.12% of its industry peers.
Industry RankSector Rank
ROA -65.02%
ROE -72.55%
ROIC N/A
ROA(3y)-139.6%
ROA(5y)N/A
ROE(3y)-174.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRU.CA Yearly ROA, ROE, ROICTRU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for TRU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRU.CA Yearly Profit, Operating, Gross MarginsTRU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, TRU has about the same amount of shares outstanding.
There is no outstanding debt for TRU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TRU.CA Yearly Shares OutstandingTRU.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
TRU.CA Yearly Total Debt VS Total AssetsTRU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

TRU has an Altman-Z score of -2.32. This is a bad value and indicates that TRU is not financially healthy and even has some risk of bankruptcy.
TRU has a worse Altman-Z score (-2.32) than 60.76% of its industry peers.
TRU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.32
ROIC/WACCN/A
WACCN/A
TRU.CA Yearly LT Debt VS Equity VS FCFTRU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M

2.3 Liquidity

TRU has a Current Ratio of 9.64. This indicates that TRU is financially healthy and has no problem in meeting its short term obligations.
TRU has a better Current ratio (9.64) than 85.82% of its industry peers.
TRU has a Quick Ratio of 9.64. This indicates that TRU is financially healthy and has no problem in meeting its short term obligations.
TRU has a Quick ratio of 9.64. This is amongst the best in the industry. TRU outperforms 85.82% of its industry peers.
Industry RankSector Rank
Current Ratio 9.64
Quick Ratio 9.64
TRU.CA Yearly Current Assets VS Current LiabilitesTRU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.45% over the past year.
EPS 1Y (TTM)61.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRU.CA Price Earnings VS Forward Price EarningsTRU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRU.CA Per share dataTRU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TRU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRU PRECIOUS METALS CORP

TSX-V:TRU (5/15/2025, 7:00:00 PM)

0.025

+0.01 (+25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.17%
Inst Owner ChangeN/A
Ins Owners4.08%
Ins Owner ChangeN/A
Market Cap4.11M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.63
P/tB 2.63
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.02%
ROE -72.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-139.6%
ROA(5y)N/A
ROE(3y)-174.9%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.64
Quick Ratio 9.64
Altman-Z -2.32
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.36%
OCF growth 3YN/A
OCF growth 5YN/A